Perrigo Steers Through Transportation Obstacles, Soaring Shipping Costs From COVID-19

Divesting ScarAway Wound-Care Brand Required For US FTC Approval Of HRA Acquisition

Perrigo largely has resolved distribution problems, but shipping freight costs still are much higher than pre-pandemic and it must divest a wound-care brand before US regulators sign off on acquisition of HRA Pharma, says CEO Murray Kessler during J.P. Morgan conference.

• Source: Alamy

Perrigo Company PLC is working through challenges concerning not having enough of some things while having too much of one thing and paying significantly more than it historically has for another.

President and CEO Murray Kessler says, like its competitors in the global consumer health market space, Perrigo has been hit...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from International

More from Geography